Disclaimer: *Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA. Prescription required.
Ozempic® (semaglutide) and Wegovy® (semaglutide) are not compounded.
Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare provider's discretion.
Wegovy® is FDA-approved for weight loss. Ozempic® and Wegovy® are the registered trademarks of Novo Nordisk A/S. Hims, Inc. is not affiliated with or endorsed by Novo Nordisk A/S.
Not available in all 50 states. Weight Loss by Hers is a holistic program that includes nutrition support, technological tools, and medications prescribed based on what your provider determines is medically appropriate and necessary for you. See website for full details, important safety information, and restrictions, including online provider consultation requirements.
**Paid upfront in full. Actual price to customer will depend on product and subscription plan purchase.